Sponsored Content | Case Study | Mammography | March 06, 2018

Southwest Diagnostic Imaging Center Uses Artificial Intelligence to Optimize Breast Tomosynthesis Interpretations

Katherine Hall, M.D.

Katherine Hall, M.D.

Located in a spacious 25,000-square-foot facility on the Presbyterian Hospital of Dallas campus, Southwest Diagnostic Imaging Center is one of the largest freestanding imaging centers in the Dallas-Fort Worth area. Since 1985, the facility has provided thousands of patients from Texas and across the nation with the highest standard of service and a patient-centered approach to care.

 

Leading the Way

While the adoption of breast tomosynthesis is expanding, so is the innovative technology that supports these solutions. Southwest Diagnostic Imaging Center has been paving the way, equipping its radiologists with the most advanced imaging solutions for more than 30 years, and has now added artificial intelligence solution PowerLook Tomo Detection to their women’s breast health program.

To maintain competitive advantage, transitioning from 2-D to 3-D mammography, or digital breast tomosynthesis (DBT), was the imaging center’s next step. However, with nearly 12,000 mammograms conducted each year, finding a cutting-edge solution that ensured both accuracy and efficiency was crucial.

“Previously running a facility that used DBT for many years, I knew first-hand the incredible benefits and challenges radiologists face with the technology,” said Katherine Hall, M.D., radiologist and co-director of mammography, east division, at Southwest Diagnostic Imaging Center. “While I was eager to make the switch from 2-D to DBT to better serve our patients, I also expected some internal resistance, as going from reading just a few images in 2-D to reading hundreds of images per patient with DBT can be both tiresome and time-intensive for radiologists.”

 

Conducting the Search

In May 2016 Southwest Diagnostic Imaging Center conducted an extensive review of all existing tomosynthesis technologies on the market, ultimately deciding to implement GE Healthcare’s DBT solution. In doing so, the facility was also able to take advantage of iCAD’s PowerLook Tomo Detection.

Specifically, PowerLook Tomo Detection reduces the need to scroll through hundreds of images. Rather, it utilizes deep learning to pick up the highest densities and areas of distortion on a mammogram, extracts them and blends them onto a synthetic 2-D image.

“Instead of looking at 80-90 planes or more per projection for those patients with large breasts, PowerLook Tomo Detection leads me directly to the images that are most critical to review,” said Hall. “I am then able to click on that area in the preview and the solution takes me directly to the location needing further evaluation. In fact, any suspicious masses or distortions on the image are so clear that they literally pop out at you.”

 

Reducing Read Time, Improving Workflow

After four months, Southwest Diagnostic Imaging Center’s radiologists are reaping the benefits of PowerLook Tomo Detection. In fact, not only did PowerLook Tomo Detection help Hall move to an all 3-D protocol, she’s also cut down her reading time anywhere from 25-50 percent. “We want to ensure quality care for our patients and with the adoption I feel confident to utilize a 3-D only protocol. This is a benefit to our patients as it is a reduction in radiation dose exposure,”she said.

“As radiologists, when we’re amassed with information and are in a state of image overload, we all need help seeing,” continued Hall. “PowerLook Tomo Detection has been a game changer. It helps me collimate and focus on what I really need to look at and evaluate, which is what I rely on to provide my patients with the best possible care.”

Case study supplied by iCAD.

Related Content

Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur